person

Armando S.

Country
Italy
Department
U.O. di Oncologia Medica ed Ematologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
576
Sites with multiple studies

Has run more than one trial at 576 of 895 partner sites.

Specializations

Solid Tumor Oncology

The investigator concentrates on the therapeutic management of advanced solid malignancies, emphasizing molecularly driven treatment strategies across diverse organ sites.

  • Non‑small cell lung cancer
  • Metastatic breast cancer
  • Gastro‑intestinal adenocarcinomas
  • Melanoma
  • Rare squamous cell carcinomas (anal, cervical, vulvar)

Research integrates targeted agents, immunotherapies, and biomarker‑guided patient selection.

Hematologic Malignancies

Focused on innovative approaches for blood‑derived cancers, the investigator addresses both acute and chronic disease entities.

  • Acute myeloid leukemia
  • Chronic lymphocytic leukemia
  • Diffuse large B‑cell lymphoma
  • Multiple myeloma
  • Myelodysplastic syndromes

Efforts prioritize genomic profiling, cellular therapies, and resistance mitigation.

Liver Disease & Metabolic Disorders

In the hepatology arena, the investigator explores therapies for metabolic liver injury and primary liver cancers.

  • Non‑alcoholic steatohepatitis (NASH)
  • Hepatocellular carcinoma
  • Cholangiocarcinoma
  • Metabolic dysfunction‑associated steatohepatitis (MASH)
  • Fibrosis regression strategies

Studies integrate metabolic risk modification with disease‑modifying agents.

Autoimmune & Inflammatory Diseases

The investigator’s portfolio includes chronic immune‑mediated conditions that require targeted immunomodulation.

  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Atopic dermatitis
  • Inflammatory bowel disease (Crohn’s & ulcerative colitis)
  • Psoriasis

Research emphasizes pathway‑specific biologics and safety in refractory populations.

Cardiovascular & Thrombotic Disorders

Cardiovascular investigations target both atherosclerotic disease and arrhythmic complications.

  • Atrial fibrillation
  • Heart failure with preserved ejection fraction
  • Atherosclerotic cardiovascular disease
  • Thromboembolic prevention
  • Cardiovascular outcomes after myocardial infarction

Efforts focus on novel anticoagulants, risk‑reduction strategies, and mechanistic biomarkers.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.